Stocks · Healthcare · Medical - Devices
Tandem Diabetes Care, Inc. TNDM
$16.52 +0.12% Close, Oct 5, 2026 · NASDAQ · Market cap $1.13B
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -4.1% from -17.8% a year earlier.
- The stock is 42% below its highest close of the past year.
- Revenue over the last four quarters was $1.04B, down 7.1% from a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 22%
- Revenue growth, 3-year CAGRBottom 45%
- Revenue growth accelerationBottom 50%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 37%
- Gross marginBottom 41%
- Operating marginTop 46%
- Accruals (lower is better)Bottom 42%
- Interest coverBottom 40%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 45%
- Free-cash-flow yieldTop 43%
- EBITDA / enterprise valueTop 42%
- Sales / enterprise valueTop 22%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 30%
- 6-month returnBottom 28%
- 1-year return vs S&P 500Top 40%
- Distance from 52-week highBottom 35%
- Trend checklist (0–4)Bottom 36%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 18%
- Consecutive EPS beatsTop 25%
- Share of analysts rating BuyBottom 27%
- Upside to consensus price targetTop 42%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 34%
- Maximum drawdown, 3 yearsBottom 31%
- Beta vs S&P 500 (lower is better)Top 22%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -6.8% | -7.1% | ↓ |
| Gross margin | 47.0% | 56.0% | ↑ |
| Operating margin | -17.8% | -4.1% | ↑ |
| FCF margin | -0.7% | -2.6% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -7.1% | -6.8% | ↓ | Bottom 22% |
| Gross margin | 56.0% | 47.0% | ↑ | Bottom 41% |
| Operating margin | -4.1% | -17.8% | ↑ | Top 46% |
| Net margin | -6.1% | -18.3% | ↑ | — |
| Free-cash-flow margin | -2.6% | -0.7% | ↓ | — |
| Return on invested capital | -4.7% | — | Top 37% | |
| Revenue growth, 3-year CAGR | 8.2% | — | Bottom 45% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.0%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 7.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +33.3 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -5.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.09%
- Shareholder yield
- -0.09%
- Share count change, 1 year
- +2.0%
- Share count change, 3-year CAGR
- +1.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +29.5%
- Average 2-day reaction, last 8
- -1.7%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $30.17
- Target vs current price
- +82.6%
- Analysts with a rating
- 39
- Share rating Buy or Strong Buy
- 62%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +3.3% | -4.1% | +19.7% | +5.0% | — |
| May 7, 2026 | +34.8% | +2.4% | -21.7% | +7.9% | +11.5% |
| Feb 19, 2026 | +80.0% | -2.2% | +37.3% | +25.9% | -25.3% |
| Nov 6, 2025 | +0.0% | -9.1% | +23.1% | +41.2% | +32.5% |
| Aug 6, 2025 | -20.0% | -5.0% | -26.7% | -18.5% | +0.0% |
| Apr 30, 2025 | -11.7% | +0.5% | +27.1% | +26.1% | -5.2% |
| Feb 26, 2025 | +104.3% | +0.7% | -41.5% | -39.4% | -35.1% |
| Nov 6, 2024 | +12.5% | +3.4% | -6.1% | -2.5% | +8.7% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.31 | -$0.32 | +3.3% | $254.6M |
| May 7, 2026 | -$0.30 | -$0.46 | +34.8% | $247.2M |
| Feb 19, 2026 | -$0.01 | -$0.05 | +80.0% | $290.4M |
| Nov 6, 2025 | -$0.31 | -$0.31 | +0.0% | $249.3M |
| Aug 6, 2025 | -$0.48 | -$0.40 | -20.0% | $240.7M |
| Apr 30, 2025 | -$0.67 | -$0.60 | -11.7% | $234.4M |
| Feb 26, 2025 | $0.01 | -$0.23 | +104.3% | $252.4M |
| Nov 6, 2024 | -$0.35 | -$0.40 | +12.5% | $242.9M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 1.74× | — | — | Top 22% |
| Free-cash-flow yield | -2.35% | — | — | Top 43% |
| Earnings yield | -5.62% | — | — | Top 45% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +1.9%
- 200-day average slope (20 days)
- -1.9%
- Distance from 50-day average
- -15.3%
- Distance from 200-day average
- -14.9%
- RSI (14)
- 40.4
- Relative volume
- 0.79×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 65.1%
- Volatility vs own 5-year history
- 43th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.62
- Correlation with S&P 500
- 0.13
- Current drawdown from 1-year high
- -41.5%
- Maximum drawdown, 3 years
- -81.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 28, 2021 | Aug 11, 2025 | -93.4% | 907 days | Not yet recovered |
| Oct 13, 2020 | May 13, 2021 | -36.8% | 146 days | 80 days (Sep 7, 2021) |
| Nov 17, 2021 | Dec 1, 2021 | -12.5% | 9 days | 10 days (Dec 15, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.13B
- EPS, diluted (TTM)
- -$0.93
- Revenue (TTM)
- $1.04B
- 52-week range
- $12.26 – $29.65
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $702.8M | $801.2M | $747.7M | $940.2M | $1.01B |
| Gross profit | $376.2M | $413.0M | $367.7M | $489.6M | $530.8M |
| Operating income | $22.7M | -$92.8M | -$233.2M | -$99.1M | -$78.1M |
| Net income | $15.6M | -$94.6M | -$222.6M | -$96.0M | -$204.7M |
| EPS (diluted) | $0.24 | -$1.47 | -$3.43 | -$1.47 | -$3.04 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $363.3M | $282.6M | $234.4M | $240.7M | $249.3M | $290.4M | $247.2M | $254.6M |
| Net income | -$23.3M | $755,000 | -$130.6M | -$52.4M | -$21.2M | -$589,000 | -$20.4M | -$21.2M |
| EPS (diluted) | -$0.35 | $0.01 | -$1.97 | -$0.78 | -$0.31 | -$0.01 | -$0.30 | -$0.31 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $111.4M | $50.5M | -$31.8M | $24.2M | -$9.7M |
| Capital expenditure | -$23.5M | -$34.1M | -$26.8M | -$19.2M | -$19.9M |
| Free cash flow | $87.8M | $16.4M | -$58.6M | $5.0M | -$29.7M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $0 | $17.6M | $0 | -$36.7M | -$2.6M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $456.0M
- Total assets
- $1.15B
- Total liabilities
- $1.02B
- Total debt
- $739.3M
- Net debt
- $676.4M
- Shareholders’ equity
- $130.4M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 12,474,385
- Days to cover
- 7.89
- Change vs previous report
- +6.1%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Oct 10, 2017
- 1-for-10